Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in COVID-19 Pneumonia (COVITOZ-01)
NCT04435717Phase 2Terminated
- Sponsor
- Ramón y Cajal University Hospital
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in COVID-19 pneumonia, sponsored by Ramón y Cajal University Hospital. Started May 2020; status: terminated.
02
Drugs
tocilizumab
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04435717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435717.